Alseres Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alseres Pharmaceuticals

ALSE 0.00500

0.0%

Oct 18 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: paul yager who wrote (38)	8/26/1996 2:34:00 PM
From: rkrw	of 975

Paul, I was just looking over these BLSI postings, I do not own this, but a friend does. From looking at these comments I believe people to be unaware that BLSI has well over 100 million shares outstanding. I guess it is at around 150 million. They just keep issuing shares to support their expenses. So your price target of $14 figuring a share base of around 200 million eventually calculates to a MV of $2.8 Billion. This is not even close to being realistic. Keep in mind that Greenwich Pharmaceutical, the original developer of the Arthritis drug began clinicals on this drug around 1977. Twenty Years Ago!!!!If this stock works out I would guess a more realistic value would be around $2-$3 per share. The Zeneca partnership is about the only positive I see here.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next